Trevi Therapeutics, Inc. (TRVI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Trevi Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -42.49x | -8.69x | -4.57x | -4.27x | -0.53x | -1.33x |
| P/B Ratio | 9.91x | 4.18x | 1.61x | 1.16x | 1.05x | 1.60x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 19.66x | 10.41x | 15.03x | 9.15x | 2.98x | 8.33x |
| Quick Ratio | 19.66x | 10.41x | 15.03x | 9.15x | 2.98x | 8.33x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.01x | 0.02x | 0.09x | 0.86x | 0.52x |
YoY = year-over-year change. Source: FMP..